Shanghai Labway Clinical Laboratory Co., Ltd (SHE:301060)
China
· Delayed Price · Currency is CNY 10.69
+0.18 (1.71%)
Mar 10, 2026, 10:19 AM CST
SHE:301060 Market Cap
SHE:301060 has a market cap or net worth of 4.19 billion as of March 9, 2026. Its market cap has decreased by -1.50% in one year.
Market Cap
4.19B
Enterprise Value
3.74B
Revenue
1.52B
Ranking
n/a
PE Ratio
n/a
Stock Price
10.69
Market Cap Chart
Since September 13, 2021, SHE:301060's market cap has decreased from 7.32B to 4.19B, a decrease of -42.76%. That is a compound annual growth rate of -11.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 4.19B | 13.62% |
| Dec 31, 2025 | 3.69B | 1.45% |
| Dec 31, 2024 | 3.63B | -31.73% |
| Dec 29, 2023 | 5.32B | -32.23% |
| Dec 30, 2022 | 7.85B | -43.54% |
| Dec 31, 2021 | 13.91B | 90.09% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Berry Genomics Co.,Ltd | 4.18B |
| Guangdong Hybribio Biotech | 4.14B |
| Medicalsystem Biotechnology | 3.92B |
| Thalys Medical Technology Group | 4.78B |
| SMO ClinPlus CO.,LTD. | 5.06B |
| Chemclin Diagnostics | 2.98B |
| Cowealth Medical China | 6.62B |
| Maccura Biotechnology Co.Ltd | 6.95B |